Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cesium fluoride | HCID 25953 | — |
| Reactant | Tributylvinyltin | HCID 81998 | — |
| Reactant | HCID 136216236 | HCID 136216236 | — |
| Catalyst | Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI) | HCID 24350 | — |
| Catalyst | HCID 178418397 | HCID 178418397 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 136216273 | HCID 136216273 | 63% |
Reaction Steps
To a degassed mixture of 4-(2-bromo-4-chloro-phenyl)-1-methyl-3-(2-pyridyl)-4,6,7,8-tetrahydropyrazolo[3,4-e][1,4]thiazepine (0.50 g, 1.2 mmol, Example #D.37) and tributyl(vinyl)stannane (0.37 mL, 1.3 mmol) in DMF (5 mL) was added cesium fluoride (0.35 g, 2.3 mmol), copper(I) iodide (0.022 g, 0.12 mmol) and tetrakis(triphenylphosphine)palladium(0) (0.066 g, 0.058 mmol). The resulting mixture was heated at about 45° C. overnight; then diluted with DCM (50 mL), washed with water (20 mL) and brine (20 mL), dried (MgSO4), filtered and concentrated in vacuo. The residue was purified by column chromatography (SiO2, ethyl acetate/hexanes 1:1) to give 4-(4-chloro-2-vinyl-phenyl)-1-methyl-3-(2-pyridyl)-4,6,7,8-tetrahydropyrazolo[3,4-e][1,4]thiazepine (0.28 g, 0.73 mmol, 63%) as an off white solid: LC-MS (Table 1, Method a) Rt=4.07 min; m/z 383 (M+H)+; 1H-NMR (CDCl3, Bruker 400 MHz) 2.69-2.78 (1 H, m) 2.81-2.89 (1 H, m) 3.19-3.28 (1 H, m) 3.52-3.61 (1 H, m) 3.77-3.86 (1 H, m) 3.84 (3 H, s) 5.47 (1 H, dd, J=11.0, 1.5 Hz) 5.73 (1 H, dd, J=17.5, 1.5 Hz) 6.79 (1 H, s) 7.02-7.08 (2 H, m) 7.14 (1 H, d, J=8.5 Hz) 7.38 (1 H, dd, J=17.5, 11.0 Hz) 7.45 (1 H, d, J=2.0 Hz) 7.58 (1 H, td, J=7.5, 2.0 Hz) 7.77 (1 H, br.d, J=8.0 Hz) 8.42 (1 H, br.d, J=5.0 Hz).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09150592B2 |
|---|
| Source dataset | uspto-grants-2015_10 |
|---|
| ORD ID | ord-45f9aa04576149a0997814bab8b3b0b3 |
|---|
| Source note | uspto-grants-2015_10 |
|---|